Anti-SMAD5 antibody [EP619Y]
- 20ul selling size
- KO Validated
- RabMAb
- Recombinant
- What is this?
5
(4 Reviews)
|
(51 Publications)
Rabbit Recombinant Monoclonal SMAD5 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, African green monkey, Human, Rat samples. Cited in 51 publications.
View Alternative Names
MADH5, SMAD5, Mothers against decapentaplegic homolog 5, MAD homolog 5, Mothers against DPP homolog 5, JV5-1, SMAD family member 5, SMAD 5, Smad5, hSmad5
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SMAD5 antibody [EP619Y] (AB40771)
Immunohistochemical staining of paraffin embedded human testis with purified ab40771 at a working dilution of 1/50. The secondary antibody used is ab97051, a goat anti-rabbit IgG (H&L) at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-SMAD5 antibody [EP619Y] (AB40771)
Immunofluorescence staining of HeLa cells with purified ab40771 at a working dilution of 1/100, counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077), used at a dilution of 1/1000. ab7291, a mouse anti-tubulin antibody (1/1000), was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse, 1/1000), shown in the top right hand panel. The cells were fixed in 4% PFA and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1, purified ab40771 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2, ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-SMAD5 antibody [EP619Y] (AB40771)
Overlay histogram showing HEK293 cells stained with unpurified ab40771 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40771, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HEK293 cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SMAD5 antibody [EP619Y] (AB40771)
Unpurified ab40771 (4μg/ml) staining SMAD5 in human skin using an automated system (DAKO Autostainer Plus). Using this protocol there is strong staining of nuclear/cytoplasmic compartments within the stratum granulosum.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-SMAD5 antibody [EP619Y] (AB40771)
Overlay histogram showing PC-12 cells fixed in 4% PFA and stained with purified ab40771 at a dilution of 1/100 (red line). The secondary antibody used was Alexa Fluorr® 488 goat anti-rabbit at a dilution of 1/500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).
- WB
Lab
Western blot - Anti-SMAD5 antibody [EP619Y] (AB40771)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-SMAD5 antibody [EP619Y] (ab40771) at 1/5000 dilution
Lane 1:
HEK293 whole cell lysate at 10 µg
Lane 2:
COS-1 whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 52 kDa
Observed band size: 52 kDa
false
- WB
Lab
Western blot - Anti-SMAD5 antibody [EP619Y] (AB40771)
Anti-SMAD5 antibody [EP619Y] (ab40771) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab40771 was shown to bind specifically to SMAD5. A band was observed at 52 kDa in wild-type HeLa cell lysates with no signal observed at this size in SMAD5 knockout cell line. To generate this image, wild-type and SMAD5 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-SMAD5 antibody [EP619Y] (ab40771) at 1/1000 dilution
Lane 1:
Wild-type HeLa Vehicle Control TGF-beta (0 ng/mL, 30 min) cell lysate at 20 µg
Lane 2:
Wild-type HeLa Treated TGF-beta (10 ng/mL, 30 min) cell lysate at 20 µg
Lane 3:
SMAD1 knockout HeLa Vehicle Control TGF-beta (0 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad1-knockout-hela-cell-line-ab265400'>ab265400</a> cell lysate at 20 µg
Lane 4:
SMAD1 knockout HeLa Treated TGF-beta (10 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad1-knockout-hela-cell-line-ab265400'>ab265400</a> cell lysate at 20 µg
Lane 5:
SMAD2 knockout HeLa Vehicle Control TGF-beta (0 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad2-knockout-hela-cell-line-ab255430'>ab255430</a> cell lysate at 20 µg
Lane 6:
SMAD2 knockout HeLa Treated TGF-beta (10 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad2-knockout-hela-cell-line-ab255430'>ab255430</a> cell lysate at 20 µg
Lane 7:
Wild-type HeLa Vehicle Control TGF-beta (0 ng/mL, 30 min), ab255448 cell lysate at 20 µg
Lane 8:
Wild-type HeLa Treated TGF-beta (10 ng/mL, 30 min), ab255448 cell lysate at 20 µg
Lane 9:
SMAD3 knockout HeLa Vehicle Control TGF-beta (0 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad3-knockout-hela-cell-line-ab255431'>ab255431</a> cell lysate at 20 µg
Lane 10:
SMAD3 knockout HeLa Treated TGF-beta (10 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad3-knockout-hela-cell-line-ab255431'>ab255431</a> cell lysate at 20 µg
Lane 11:
Wild-type HEK293 Vehicle Control TGF-beta (0 ng/mL, 30 min), ab259776 cell lysate at 20 µg
Lane 12:
Wild-type HEK293 Treated TGF-beta (10 ng/mL, 30 min), ab259776 cell lysate at 20 µg
Lane 13:
SMAD5 knockout HEK293 Vehicle Control TGF-beta (0 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad5-knockout-hek-293-cell-line-ab269470'>ab269470</a> cell lysate at 20 µg
Lane 14:
SMAD5 knockout HEK293 Treated TGF-beta (10 ng/mL, 30 min), <a href='/en-us/products/cell-lines/human-smad5-knockout-hek-293-cell-line-ab269470'>ab269470</a> cell lysate at 20 µg
Secondary
Lanes 1 - 14:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 14:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 52 kDa
false
- WB
Lab
Western blot - Anti-SMAD5 antibody [EP619Y] (AB40771)
Blocking and dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-SMAD5 antibody [EP619Y] (ab40771) at 1/1000 dilution
Lane 1:
3T3-L1 (Mouse embryonic fibroblast) lysate at 20 µg
Lane 2:
Neuro-2a (Mouse neuroblastoma neuroblast) at 20 µg
Lane 3:
F9 (Mouse embryonal carcinoma epithelial cell) lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 52 kDa
Observed band size: 52 kDa
false
Exposure time: 3min
- WB
Unknown
Western blot - Anti-SMAD5 antibody [EP619Y] (AB40771)
All lanes:
Western blot - Anti-SMAD5 antibody [EP619Y] (ab40771) at 1/1000 dilution
All lanes:
Cos-1 cell lysate at 10 µg
Predicted band size: 52 kDa
Observed band size: 52 kDa
false
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-SMAD5 antibody [EP619Y]
-
Anti-SMAD5 antibody [EP619Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SMAD5 plays a central role in the bone morphogenetic protein (BMP) signaling pathway which is critical for embryonic development and tissue homeostasis. It forms a complex with receptor-regulated SMADs (R-SMADs) and co-SMAD (SMAD4) upon phosphorylation by BMP type I receptors. This complex then moves to the nucleus where it regulates expression of target genes. Through this mechanism SMAD5 impacts processes such as bone formation differentiation and cellular differentiation.
Pathways
Several key cellular signaling processes involve SMAD5. Primarily it contributes to the BMP pathway which is integral to skeletal development and repair. SMAD5 interacts with other SMAD proteins like SMAD1 and SMAD8 which all act downstream of the BMP receptors. Additionally SMAD5 participates in crosstalk with the TGF-beta signaling pathway enabling the fine-tuning of cellular responses to a variety of external cues. This connection places SMAD5 within a network of signaling events important for regulating different cell functions and maintaining cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (51)
Recent publications for all applications. Explore the full list and refine your search
Clinical science (London, England : 1979) 139:15-27 PubMed39631055
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:98 PubMed38581019
2024
Applications
Unspecified application
Species
Unspecified reactive species
Intractable & rare diseases research 12:222-233 PubMed38024586
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta Cardiologica Sinica 39:841-853 PubMed38022420
2023
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:7616-7636 PubMed37543427
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37371129
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 29:263-273 PubMed37303938
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials research 26:78 PubMed36514131
2022
Applications
Unspecified application
Species
Unspecified reactive species
Blood 141:422-432 PubMed36322932
2022
Applications
Unspecified application
Species
Unspecified reactive species
PLoS genetics 18:e1009967 PubMed36197846
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com